422 related articles for article (PubMed ID: 30867817)
1. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
Kim H; Cho MH; Choi HS; Lee BI; Choi Y
Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
5. In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe.
Ryu JH; Shin M; Kim SA; Lee S; Kim H; Koo H; Kim BS; Song HK; Kim SH; Choi K; Kwon IC; Jeon H; Kim K
Biomaterials; 2013 Dec; 34(36):9149-59. PubMed ID: 23998858
[TBL] [Abstract][Full Text] [Related]
6. Quenched cetuximab conjugate for fast fluorescence imaging of EGFR-positive lung cancers.
Kim H; Goh SH; Choi Y
Biomater Sci; 2021 Jan; 9(2):456-462. PubMed ID: 32760993
[TBL] [Abstract][Full Text] [Related]
7. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore.
Pal R; Kang H; Choi HS; Kumar ATN
Clin Cancer Res; 2019 Nov; 25(22):6653-6661. PubMed ID: 31481509
[TBL] [Abstract][Full Text] [Related]
9. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments.
Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR
Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
[TBL] [Abstract][Full Text] [Related]
11. Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor.
Cohen G; Lecht S; Arien-Zakay H; Ettinger K; Amsalem O; Oron-Herman M; Yavin E; Prus D; Benita S; Nissan A; Lazarovici P
PLoS One; 2012; 7(11):e48803. PubMed ID: 23144978
[TBL] [Abstract][Full Text] [Related]
12. Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies.
Cohen G; Lecht S; Oron-Herman M; Momic T; Nissan A; Lazarovici P
Int J Mol Sci; 2013 Jul; 14(7):14669-88. PubMed ID: 23857061
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.
Gong H; Kovar J; Little G; Chen H; Olive DM
Neoplasia; 2010 Feb; 12(2):139-49. PubMed ID: 20126472
[TBL] [Abstract][Full Text] [Related]
14. Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.
Aayush A; Darji S; Dhawan D; Enstrom A; Broman MM; Idrees MT; Kaimakliotis H; Ratliff T; Knapp D; Thompson D
Oncotarget; 2022; 13():1004-1016. PubMed ID: 36082359
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
16. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
[TBL] [Abstract][Full Text] [Related]
17. Mini-Platform for Off-On Near-Infrared Fluorescence Imaging Using Peptide-Targeting Ligands.
Kim H; Choi HS; Eom JB; Choi Y
Bioconjug Chem; 2020 Mar; 31(3):721-728. PubMed ID: 31895549
[TBL] [Abstract][Full Text] [Related]
18. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
19. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
